Sakar Healthcare Limited (NSE:SAKAR)
India · Delayed Price · Currency is INR 882.80
-69.00 (-7.25%)
Oct 23, 2026, 3:29 PM IST
Sakar Healthcare Market Cap
Sakar Healthcare has a market cap or net worth of 19.64 billion as of October 22, 2026. It is the 19,952nd most valuable company in the world and the 1,203rd biggest in India. Its market cap has increased by 145.27% in one year.
Market Cap
19.64B
Enterprise Value
20.34B
Revenue
2.72B
Global Rank
Country Rank
#1,203 India
PE Ratio
54.49
ChartMarket Cap Chart
Since October 11, 2017, Sakar Healthcare's market cap has increased from 560.11M to 19.64B, an increase of 3,406.87%. That is a compound annual growth rate of 48.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 19.64B | 115.74% |
| Dec 31, 2025 | 9.10B | 41.21% |
| Dec 31, 2024 | 6.45B | -15.35% |
| Dec 29, 2023 | 7.62B | 82.44% |
| Dec 30, 2022 | 4.18B | 49.95% |
| Dec 31, 2021 | 2.78B | 89.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 45.98B |
| Orchid Pharma | 44.48B |
| Solara Active Pharma Sciences | 30.04B |
| Ind-Swift Laboratories | 30.00B |
| Indoco Remedies | 20.79B |
| Beta Drugs | 19.98B |
| Windlas Biotech | 18.66B |
| Jagsonpal Pharmaceuticals | 13.94B |